4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-054194
Chief Operating Officer sold 9,939 shares at $7.40 ($73,549)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2023-11-02 | Sale | −9,939 | $7.40 | $73,549 | 94,605 | D |
| Open-market sales · 9,939 sh · avg $7.40 · $73,549 | |||||||
Loading xslF345X05/doc4.xml…